TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30716525

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) with a brain target volume receiving focal radiation therapy in fractions of 1.8 Gy to a total of 50.4 Gy
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Tumor progression
Number of subjects: 195
Study: 29341463

Group type: EXPERIMENTAL
Intervention: Mixed teaching methods with a high percentage of non-phonically decodable vocabulary
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mixed teaching methods with low percentage of non-decodable vocabulary
Number of subjects: 12

Group type: COMPARATOR
Intervention: Synthetic phonics only and phonically decodable vocabulary (Control)
Number of subjects: 12
Study: 26395351

Group type: EXPERIMENTAL
Intervention: Daily tooth brushing with 500 ppm fluoride toothpaste, supervised by specially trained dental nurses.
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Tooth brushing instructions three to four times a year (Control group).
Number of subjects: 2112

Group type: COMPARATOR
Intervention: Control group (tooth brushing instructions).
Number of subjects: 2112
Study: 24210789

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000U) each week for 8 weeks plus 200mg calcium and a multivitamin (containing vitamin D3 400U)
Number of subjects: 130

Group type: COMPARATOR
Intervention: 200mg calcium plus a multivitamin (containing vitamin D3 400U)
Number of subjects: 130
Study: 22538327

Group type: EXPERIMENTAL
Intervention: Prostacyclin treatment
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CT(i) Rotterdam classification
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Marshall, Rotterdam, Morris‐Marshall classifications
Number of subjects: 48
Study: 20449689

Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PACAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study: 17518878

Group type: EXPERIMENTAL
Intervention: Serial Trial Intervention protocol
Number of subjects: 8
Study: 16130055

Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen (1 g every sixth hour)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Oral acetaminophen (1 g every sixth hour)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 12404086

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) via oral mixture of amino acids
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control mixture of amino acids
Number of subjects: 10
Study: 9701735

Group type: EXPERIMENTAL
Intervention: Electrovaporization of the prostate (TVP)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laser ablation of the prostate (LAP)
Number of subjects: 20
Study: 8539546

Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 286

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 286
Study: 2393625

Group type: EXPERIMENTAL
Intervention: Skills training and peer support intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lecture/discussion only
Number of subjects: 0
Study: 698028

Group type: EXPERIMENTAL
Intervention: Iotroxamide
Number of subjects: 0
Study: 31606734

Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitors (ISTIs)
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Dolutegravir and Bictegravir
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Rilpivirine (NNRTI)
Number of subjects: 5000

Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (NRTI)
Number of subjects: 5000
Study: 30712404

Group type: EXPERIMENTAL
Intervention: 10 mg of IM olanzapine
Number of subjects: 63

Group type: COMPARATOR
Intervention: 0.3 mg of oral clonidine
Number of subjects: 63
Study: 28303301

Group type: EXPERIMENTAL
Intervention: Tapered-cuff tracheal tube
Number of subjects: 326

Group type: COMPARATOR
Intervention: Standard-cuff tracheal tube
Number of subjects: 326
Study: 25600568

Group type: EXPERIMENTAL
Intervention: Bevacizumab with second-line chemotherapy (mFOLFOX-6 or FOLFIRI)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Chemotherapy alone (mFOLFOX-6 or FOLFIRI without bevacizumab)
Number of subjects: 185
Study: 23831423

Group type: EXPERIMENTAL
Intervention: TENS treatment for 3 weeks (1 hour per day) on the median nerve region of the most impaired hand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation for 3 weeks (1 hour per day) on the median nerve region of the most impaired hand
Number of subjects: 0
Study: 21966856

Group type: EXPERIMENTAL
Intervention: Letrozole, 2.5 mg, oral route for 36 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tamoxifen, 20 mg, oral route for 36 months
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 40
Study: 19948980

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose > or =140 mg/dL) on admission
Number of subjects: 30536

Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose > or =140 mg/dL) after admission
Number of subjects: 30536

Group type: EXPERIMENTAL
Intervention: Hypoglycemia (glucose < or =70 mg/dL) on admission
Number of subjects: 30536

Group type: EXPERIMENTAL
Intervention: Hypoglycemia (glucose < or =70 mg/dL) postadmission
Number of subjects: 30536

Group type: EXPERIMENTAL
Intervention: Hypoglycemia redefined as glucose < or =60 mg/dL
Number of subjects: 30536

Group type: EXPERIMENTAL
Intervention: Postadmission hypoglycemia in insulin-treated patients
Number of subjects: 30536
Study: 16618375

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study: 15082018

Group type: EXPERIMENTAL
Intervention: Relaxation training (listening to a 12 min relaxation tape)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (pressing a button whenever a body part was mentioned)
Number of subjects: 32
Study: 11103165

Group type: EXPERIMENTAL
Intervention: LMW heparin delivered by J-Tip
Number of subjects: 60

Group type: COMPARATOR
Intervention: LMW heparin delivered by standard needle and syringe
Number of subjects: 60
Study: 9057938

Group type: EXPERIMENTAL
Intervention: Scrub with an inert scrub brush and 4% chlorhexidine soap with isopropyl alcohol
Number of subjects: 15

Group type: COMPARATOR
Intervention: Wash with 4% chlorhexidine soap with isopropyl alcohol alone
Number of subjects: 15
Study: 8448733

Group type: EXPERIMENTAL
Intervention: Multivariate statistics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 3746543

Group type: EXPERIMENTAL
Intervention: IVIgG (12 gm in 12 hours or 24 gm on each of 5 consecutive days)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Antibiotics alone (control group)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: IVIgG (both low and high doses)
Number of subjects: 51
Study: 2453995

Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream (EMLA) applied topically, 10 g one hour before operation
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 55
Study: 31770084

Group type: EXPERIMENTAL
Intervention: Bio-sorb® cream
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no cream)
Number of subjects: 26
Study: 30993323

Group type: EXPERIMENTAL
Intervention: Daidzein and Chinese herbs mixture (0.02%)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control (basal diet)
Number of subjects: 240
Study: 27783363

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 118
Study: 25738667

Group type: EXPERIMENTAL
Intervention: Hepatitis E vaccine
Number of subjects: 56302

Group type: COMPARATOR
Intervention: Hepatitis B vaccine (control)
Number of subjects: 56302
Study: 24095985

Group type: EXPERIMENTAL
Intervention: Erythritol candies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Xylitol candies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorbitol candies
Number of subjects: 0
Study: 21255869

Group type: EXPERIMENTAL
Intervention: Nonablative 1550-nm fractional laser therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Triple topical therapy (hydroquinone 5%, tretinoin 0.05%, and triamcinolone acetonide 0.1% cream)
Number of subjects: 20
Study: 18992209

Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Artesunate
Number of subjects: 328

Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine
Number of subjects: 328

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 328
Study: 16550669

Group type: EXPERIMENTAL
Intervention: Active manuka honey dressing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paraffin-impregnated tulle gras
Number of subjects: 100
Study: 12837218

Group type: EXPERIMENTAL
Intervention: lamivudine treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: control group (10 patients)
Number of subjects: 20
Study: 10848682

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (INO) at 4 parts per million
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) at 10 cm H2O
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Combination of INO and PEEP at 10 cm H2O
Number of subjects: 11
Study: 9100140

Group type: EXPERIMENTAL
Intervention: Teamwork program between physicians and pharmacists
Number of subjects: 94

Group type: COMPARATOR
Intervention: Standard medical care (Control)
Number of subjects: 94
Study: 7951597

Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 0
Study: 3543069

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30096148

Group type: EXPERIMENTAL
Intervention: Midwife or physician for PAC including contraceptive counselling
Number of subjects: 810
Study: 27017088

Group type: EXPERIMENTAL
Intervention: High nonverbal involvement
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Low nonverbal involvement
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Written disclosure vignette without nonverbal information
Number of subjects: 318
Study: 26586327

Group type: COMPARATOR
Intervention: GLP-1 receptor agonist exenatide (acute intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: GLP-1 receptor agonist liraglutide (12-week intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: DPP-4 inhibitor sitagliptin (12-week intervention)
Number of subjects: 60
Study: 23896631

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation (45.0 Gy and boost up to 54.0 Gy plus concurrent and subsequent gemcitabine)
Number of subjects: 100
Study: 20043816

Group type: EXPERIMENTAL
Intervention: SB-742457 35 mg
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: SB-742457 5 mg
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: SB-742457 15 mg
Number of subjects: 371

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 371
Study: 17804302

Group type: EXPERIMENTAL
Intervention: School-based supervised asthma therapy
Number of subjects: 295

Group type: COMPARATOR
Intervention: Parent supervised asthma therapy
Number of subjects: 295
Study: 16644288

Group type: EXPERIMENTAL
Intervention: rhIL‐11
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12699019

Group type: EXPERIMENTAL
Intervention: C (Caffeine)
Number of subjects: 43

Group type: COMPARATOR
Intervention: P (Placebo)
Number of subjects: 43
Study: 10192233

Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5 to 10 mg/day)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Enalapril (5 to 40 mg/day)
Number of subjects: 46
Study: 7778075

Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) testing
Number of subjects: 239

Group type: COMPARATOR
Intervention: Control group (no CRP testing)
Number of subjects: 239
Study: 1970027

Group type: EXPERIMENTAL
Intervention: Doxapram infusion (2 mg per min for 6 h immediately after surgery and repeated on the first postoperative day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Doxapram infusion
Number of subjects: 39
Study: 6243527

Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxycholecalciferol (1,25[OH]2D3)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (D3)
Number of subjects: 18
Study: 31733807

Group type: EXPERIMENTAL
Intervention: Lung protection (PEEP 7 cm H2O and recruitment manoeuvres every 30 min)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Zero end-expiratory pressure (ZEEP; no recruitment manoeuvres)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lung protection (PEEP/RMs)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Zero end-expiratory pressure (ZEEP)
Number of subjects: 45
Study: 30211667

Group type: EXPERIMENTAL
Intervention: Performance-based practice
Number of subjects: 0
Study: 27849369

Group type: EXPERIMENTAL
Intervention: Assisted partner services (APS)
Number of subjects: 29
Study: 24905260

Group type: EXPERIMENTAL
Intervention: Immediate loading (Columbus Bridge Protocol) with 4 to 6 implants, loaded within 24 hours
Number of subjects: 49

Group type: COMPARATOR
Intervention: Delayed loading (two-stage surgical protocol) with 6 to 9 straight implants, loaded a mean of 8.75 months after surgery
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both immediate and delayed loading groups
Number of subjects: 49
Study: 23292055

Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 25

Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 25
Study: 19371389

Group type: EXPERIMENTAL
Intervention: Varnish applied to the tissue conditioner (Group G1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment applied (Group G2)
Number of subjects: 40
Study: 17911499

Group type: EXPERIMENTAL
Intervention: Perindopril (8 mg/d for 24 weeks)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16091984

Group type: EXPERIMENTAL
Intervention: New mattress technique
Number of subjects: 113

Group type: COMPARATOR
Intervention: Cattell technique
Number of subjects: 113
Study: 12163961

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for colon cancer
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Open surgery for colon cancer
Number of subjects: 1200
Study: 9727729

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 15 mg chlorazepate
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 50 mg oxazepam
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 7991336

Group type: EXPERIMENTAL
Intervention: Covert orienting of attention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Invalid cues
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High event rate
Number of subjects: 0
Study: 2532841

Group type: EXPERIMENTAL
Intervention: etretin (50 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: etretin (during second period of 20 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: etretin
Number of subjects: 30
Study: 29946649

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with sevoflurane (D group)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sevoflurane only (S group)
Number of subjects: 120
Study: 25223947

Group type: EXPERIMENTAL
Intervention: Proximal Chevron Metatarsal Osteotomy (PCMO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distal Chevron Metatarsal Osteotomy (DCMO)
Number of subjects: 60
Study: 23632203

Group type: EXPERIMENTAL
Intervention: Low-glycaemic index Brazilian diet combined with DASH principles
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard care focused on salt intake reduction (Control Group)
Number of subjects: 206
Study: 21620395

Group type: EXPERIMENTAL
Intervention: Oral contraceptives (OC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19445822

Group type: EXPERIMENTAL
Intervention: Caffeine alone (150 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Caffeine plus a catechin mixture (600 mg) enriched in EGCG
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 16786231

Group type: EXPERIMENTAL
Intervention: Abciximab facilitated primary angioplasty (FP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: On-site fibrin-specific thrombolytic therapy (TT)
Number of subjects: 48
Study: 14962331

Group type: EXPERIMENTAL
Intervention: Roc 0.4 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Miv 0.133 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Roc 0.32 + Miv 0.027 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Roc 0.24 + Miv 0.053 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Roc 0.16 + Miv 0.08 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Roc 0.08 + Miv 0.106 mg.kg(‐1)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Combination groups (Roc + Miv)
Number of subjects: 68
Study: 11098963

Group type: EXPERIMENTAL
Intervention: Filgrastim 300 microg subcutaneously once daily for 7 days
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 59
Study: 9049456

Group type: EXPERIMENTAL
Intervention: Electrolyte-poor water supplementation (2 L/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: HCO3-rich water supplementation (2 L/day, 47.5 mmol/L)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no specific control mentioned)
Number of subjects: 11
Study: 8075257

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (3 g every 6 hours)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (500 mg every 6 hours)
Number of subjects: 96
Study: 2587285

Group type: EXPERIMENTAL
Intervention: CVM exercise with a resistance device
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CVM exercise without a device
Number of subjects: 48

Group type: COMPARATOR
Intervention: No exercise with device in place
Number of subjects: 48
Study: 1266792

Group type: EXPERIMENTAL
Intervention: Diet meeting NIH criteria for type II or IV hyperlipoproteinemia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet controlled in fat
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIH type IV diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diet controlled in fat with caloric restriction
Number of subjects: 0
Study: 31181206

Group type: EXPERIMENTAL
Intervention: NI-VATS
Number of subjects: 198
Study: 30684398

Group type: EXPERIMENTAL
Intervention: Text message reminders to use selected postabortion contraceptive methods
Number of subjects: 120

Group type: COMPARATOR
Intervention: No text message reminders
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Text message reminders
Number of subjects: 120
Study: 26176074

Group type: EXPERIMENTAL
Intervention: No-touch isolation technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional hepatectomy
Number of subjects: 80
Study: 21707184

Group type: EXPERIMENTAL
Intervention: Suppress intrusive thought
Number of subjects: 100

Group type: COMPARATOR
Intervention: Monitor intrusive thought
Number of subjects: 100
Study: 20693570

Group type: EXPERIMENTAL
Intervention: Self-reported answer to a screening question about binge drinking (5 or more standard drinks on one occasion) within the past 90 days
Number of subjects: 354

Group type: COMPARATOR
Intervention: Self-reported answer to a question about drinking quantity (weekly consumption of 8 or more standard drinks) within the past 90 days
Number of subjects: 354
Study: 18831420

Group type: EXPERIMENTAL
Intervention: Akten 1.5%
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Akten 2.5%
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Akten 3.5%
Number of subjects: 209

Group type: COMPARATOR
Intervention: Sham gel
Number of subjects: 209
Study: 16098074

Group type: EXPERIMENTAL
Intervention: Intensified treatment arm (idarubicin 42 mg/m2, melphalan 200 mg/m2, cyclophosphamide 120 mg/kg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard treatment arm (melphalan 200 mg/m2)
Number of subjects: 56
Study: 12444815

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 1955

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1955

Group type: EXPERIMENTAL
Intervention: Lamotrigine (open-label)
Number of subjects: 1955
Study: 10616771

Group type: EXPERIMENTAL
Intervention: OAC1w (omeprazole 20mg bid + amoxicillin 1000mg bid + clarithromycin 400mg bid for 1 week)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: OAC2w (omeprazole 20mg bid + amoxicillin 1000mg bid + clarithromycin 400mg bid for 2 weeks)
Number of subjects: 147
Study: 8572853

Group type: COMPARATOR
Intervention: Consultation tailored to needs (C)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: One-hour course about diet (CC)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 300
Study: 2695413

Group type: EXPERIMENTAL
Intervention: Naproxen sodium (550 mg twice daily, from day -7 to the 4th day of the cycle)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (for the first three cycles)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 28
Study: 321147

Group type: EXPERIMENTAL
Intervention: Acetyl strophanthanin (0.5 mg initially, followed by 0.25 mg four hours later)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no acetyl strophanthanin)
Number of subjects: 59
Study: 31273965

Group type: EXPERIMENTAL
Intervention: Deep Cleaning Device
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control (artificial tears and lid warming)
Number of subjects: 15
Study: 28196066

Group type: EXPERIMENTAL
Intervention: Patient education program
Number of subjects: 212

Group type: COMPARATOR
Intervention: Standard of care (Control)
Number of subjects: 212
Study: 25664155

Group type: EXPERIMENTAL
Intervention: Nefopam 40 mg mixed with normal saline 100 ml (Group N)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 50
Study: 23307959

Group type: EXPERIMENTAL
Intervention: 300 mg PEA, twice a day for three months (T1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 300 mg PEA, after washout period (T3)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo, after washout period (T3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Baseline measurements
Number of subjects: 40